中国甲状腺眼病患者的临床特征:一项多中心回顾性研究
该多中心回顾性研究纳入2016年2月至2023年7月中国九家医院的4157例甲状腺眼病患者,按欧洲Graves眼病组标准评估疾病严重程度与活动性。结果显示55.6%处于非活动期,82.5%为中重度,8.2%为威胁视力;碘131治疗者活动性更高,沿海地区患者病情更重。列线图预测威胁视力TED的AUC为0.742,预测静脉糖皮质激素治疗反应的AUC为0.759。
要点
- 4157例中国TED患者中,中重度占82.5%,威胁视力占8.2%,非活动期占55.6%。
- 碘131治疗者疾病活动性高于未治疗者(47.5% vs 43.5%,p<0.05)。
- 沿海地区患者威胁视力病例多于内陆(10.1% vs 7.2%),复视评分更高。
核心结论
- 研究描述了中国大型队列中甲状腺眼病的临床特征和治疗反应,为亚洲患者TED风险分层提供信息,并为未来前瞻性研究奠定基础。
研究设计与样本
- 多中心回顾性研究,纳入2016年2月至2023年7月中国九家医院的4157例甲状腺眼病患者。
- 按欧洲Graves眼病组标准评估疾病严重程度和活动性。
- 采用逻辑回归和列线图模型分析与威胁视力TED的关联,并在亚组(n=126)中分析静脉糖皮质激素治疗反应性。
主要发现
- 患者平均年龄45.96±16.44岁,女性占63.6%(n=2644)。
- 55.6%(n=2310)处于非活动期,全部患者平均临床活动评分为2.19±1.61。
- 严重程度分布为轻度9.3%(n=385)、中重度82.5%(n=3428)、威胁视力8.2%(n=344)。
- 平均突眼度20.04±5.27 mm,48.8%(n=2029)患者有复视。
- 碘131治疗者疾病活动性高于未治疗者(47.5%,n=468 vs 43.5%,n=1379,p<0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Thyroid eye disease (TED) is a debilitating autoimmune disorder linked to thyroid dysfunction. There is limited knowledge of TED in Asian populations. This multicenter study characterizes the clinical features and treatment response of TED in a large Chinese cohort. Methods: A retrospective multicenter study included 4157 patients with TED from nine Chinese hospitals from February 2016 to July 2023. Disease severity and activity were evaluated according to the European Group on Graves' Orbitopathy standards. We examined associations of variables including sex, age, smoking status, I131 treatment, consultation department, and geographical region with clinical outcomes. Logistic regression and nomogram models were developed to examine associations with sight-threatening TED and, in a subgroup analysis (n = 126), patients' responsiveness to intravenous glucocorticoid (IVGC) therapy. Results: We included 4157 patients with mean age and standard deviation (SD) 45.96 ± 16.44 years. Of these, 63.6% (n = 2644) were females. Over half (55.6%, n = 2310) of participants were in the inactive phase, with a mean clinical activity score of 2.19 ± 1.61 (SD) for all patients. TED severity was categorized as mild (9.3%, n = 385), moderate-to-severe (82.5%, n = 3428), and sight-threatening (8.2%, n = 344). The average degree of exophthalmos was 20.04 ± 5.27 mm, and 48.8% (n = 2029) of patients had diplopia. Patients treated with I131 had higher disease activity (47.5%, n = 468, vs. 43.5%, n = 1379, p < 0.05). Coastal region patients exhibited more severe TED (sight-threatening cases: 10.1%, n = 195, vs. 7.2%, n = 147) and higher diplopia scores (1.00 ± 1.10 vs. 0.86 ± 1.09, p < 0.001) than inland counterparts. TED severity was also greater in patients treated in Ophthalmology departments (mild cases: 6.0%, n = 213; moderate-to-severe cases: 85.6%, n = 3055) compared with Endocrinology departments (mild cases: 29.3%, n = 172; moderate-to-severe cases: 63.5%, n = 373). Nomograms had an area under the receiver operating curve of 0.742 (confidence interval [CI] 0.716-0.768) for sight-threatening TED and 0.759 (CI 0.674-0.843) for IVGC therapy responsiveness. Conclusions: We characterized the clinical features and treatment response of TED in a large Chinese cohort. These findings offer valuable insights informing TED risk stratification in Asian patients and forming a foundation for future prospective studies.
引用
- Lei C, Lyu X, Ren Y, et al. Clinical Features of Chinese Patients with Thyroid Eye Disease: A Multicenter Retrospective Study. Thyroid. 2025. PMID: 40658134. doi:10.1177/10507256251359559
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。